NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $237,000 | -26.2% | 2,600 | -30.7% | 0.02% | -32.4% |
Q1 2021 | $321,000 | -46.1% | 3,750 | -40.5% | 0.04% | -47.9% |
Q4 2020 | $595,000 | -22.7% | 6,300 | -28.8% | 0.07% | -25.3% |
Q3 2020 | $770,000 | -0.4% | 8,850 | 0.0% | 0.10% | -11.2% |
Q2 2020 | $773,000 | +1.3% | 8,850 | -4.3% | 0.11% | -15.7% |
Q1 2020 | $763,000 | -12.9% | 9,250 | 0.0% | 0.13% | +11.4% |
Q4 2019 | $876,000 | +6.1% | 9,250 | -2.6% | 0.11% | -2.6% |
Q3 2019 | $826,000 | -7.2% | 9,500 | -2.6% | 0.12% | -3.3% |
Q2 2019 | $890,000 | -5.0% | 9,750 | 0.0% | 0.12% | -7.6% |
Q1 2019 | $937,000 | -11.8% | 9,750 | -21.2% | 0.13% | -22.9% |
Q4 2018 | $1,062,000 | -0.2% | 12,380 | +0.2% | 0.17% | +18.1% |
Q3 2018 | $1,064,000 | +13.2% | 12,350 | -0.8% | 0.14% | +5.1% |
Q2 2018 | $940,000 | -6.7% | 12,450 | 0.0% | 0.14% | -9.3% |
Q1 2018 | $1,007,000 | -9.8% | 12,450 | -6.4% | 0.15% | -7.9% |
Q4 2017 | $1,117,000 | -4.4% | 13,300 | -2.2% | 0.16% | -9.9% |
Q3 2017 | $1,168,000 | -2.2% | 13,600 | -4.9% | 0.18% | -2.7% |
Q2 2017 | $1,194,000 | +2.4% | 14,300 | -8.9% | 0.19% | -2.1% |
Q1 2017 | $1,166,000 | -13.5% | 15,700 | -15.1% | 0.19% | -22.0% |
Q4 2016 | $1,348,000 | -15.9% | 18,500 | -8.9% | 0.24% | -15.5% |
Q3 2016 | $1,603,000 | -9.8% | 20,300 | -5.8% | 0.29% | -7.1% |
Q2 2016 | $1,778,000 | +12.8% | 21,550 | -0.9% | 0.31% | +6.8% |
Q1 2016 | $1,576,000 | -16.6% | 21,750 | -0.9% | 0.29% | -17.5% |
Q4 2015 | $1,889,000 | -6.4% | 21,950 | 0.0% | 0.35% | -9.2% |
Q3 2015 | $2,018,000 | -6.9% | 21,950 | -0.5% | 0.39% | -1.0% |
Q2 2015 | $2,168,000 | -0.5% | 22,050 | -0.2% | 0.39% | -3.2% |
Q1 2015 | $2,179,000 | +6.4% | 22,100 | 0.0% | 0.41% | +10.9% |
Q4 2014 | $2,048,000 | -3.7% | 22,100 | -2.2% | 0.37% | -10.9% |
Q3 2014 | $2,127,000 | +3.1% | 22,600 | -0.9% | 0.41% | +3.3% |
Q2 2014 | $2,064,000 | +5.2% | 22,800 | -1.2% | 0.40% | -1.7% |
Q1 2014 | $1,962,000 | +5.8% | 23,080 | 0.0% | 0.41% | +6.3% |
Q4 2013 | $1,855,000 | -0.2% | 23,080 | -4.7% | 0.38% | -11.0% |
Q3 2013 | $1,858,000 | -58.5% | 24,225 | -61.8% | 0.43% | -59.6% |
Q2 2013 | $4,479,000 | – | 63,350 | – | 1.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |